Loading...
Mizuho Medy Co.,Ltd.
4595.T•JPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥1426.00
¥3.00(0.21%)
Mizuho Medy Co.,Ltd. (4595.T) Financial Performance & Income Statement Overview
Review Mizuho Medy Co.,Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.00%
↑ 4.00%
Operating Income Growth
-4.56%
↓ 4.56%
Net Income Growth
-0.03%
↓ 0.03%
Operating Cash Flow Growth
-16.13%
↓ 16.13%
Operating Margin
42.25%
↑ 42.25%
Gross Margin
70.85%
↑ 70.85%
Net Profit Margin
31.58%
↑ 31.58%
ROE
21.60%
↑ 21.60%
ROIC
26.63%
↑ 26.63%
Mizuho Medy Co.,Ltd. (4595.T) Income Statement & Financial Overview
Review Mizuho Medy Co.,Ltd.'s (4595.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.44B | $3.32B | $1.93B | $2.74B |
| Cost of Revenue | $1.08B | $870.00M | $604.00M | $786.00M |
| Gross Profit | $2.35B | $2.45B | $1.32B | $1.96B |
| Gross Profit Ratio | $0.68 | $0.74 | $0.69 | $0.71 |
| R&D Expenses | $783.00M | $0.00 | $0.00 | $164.00M |
| SG&A Expenses | $90.00M | $814.00M | $731.00M | $539.00M |
| Operating Expenses | $919.00M | $813.00M | $731.00M | $703.00M |
| Total Costs & Expenses | $2.004B | $1.68B | $1.33B | $1.49B |
| Interest Income | $0.00 | $0.00 | $16.00M | $20.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $60.00M | $48.75M | -$1.00M | $55.00M |
| EBITDA | $1.49B | $1.69B | $590.00M | $1.30B |
| EBITDA Ratio | $0.43 | $0.51 | $0.31 | $0.47 |
| Operating Income | $1.44B | $1.64B | $591.00M | $1.25B |
| Operating Income Ratio | $0.42 | $0.49 | $0.31 | $0.46 |
| Other Income/Expenses (Net) | $173.00M | -$161.00M | $118.00M | $120.00M |
| Income Before Tax | $1.61B | $1.48B | $709.00M | $1.37B |
| Income Before Tax Ratio | $0.47 | $0.44 | $0.37 | $0.50 |
| Income Tax Expense | $386.00M | $416.00M | $189.00M | $402.00M |
| Net Income | $1.22B | $1.06B | $519.00M | $970.00M |
| Net Income Ratio | $0.36 | $0.32 | $0.27 | $0.35 |
| EPS | $64.20 | $27.85 | $27.25 | $101.84 |
| Diluted EPS | $64.20 | $27.85 | $27.25 | $101.84 |
| Weighted Avg Shares Outstanding | $19.05M | $38.10M | $19.05M | $9.52M |
| Weighted Avg Shares Outstanding (Diluted) | $19.05M | $38.10M | $19.05M | $9.52M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan